Bryan Fellman
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, PARP inhibition in cancer therapy, Cancer survivorship and care, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence(2017)315 cited
- → ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer(2021)216 cited
- → Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer(2023)179 cited
- → Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions(2018)127 cited
- → Overall survival after pelvic exenteration for gynecologic malignancy(2014)110 cited
- → Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer(2020)110 cited
- → Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients(2017)108 cited
- → Efficacy Trial of An Internet-Based Intervention for Cancer-Related Female Sexual Dysfunction(2013)107 cited
- → Illness Uncertainty and Quality of Life of Patients with Small Renal Tumors Undergoing Watchful Waiting: A 2-year Prospective Study(2013)105 cited
- → Programmed cell death ligand 1 and tumor‐infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation(2017)102 cited